Commodore Capital LP Celldex Therapeutics, Inc. Transaction History
Commodore Capital LP
- $1.12 Billion
- Q2 2024
A detailed history of Commodore Capital LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Commodore Capital LP holds 1,425,000 shares of CLDX stock, worth $62.9 Million. This represents 4.73% of its overall portfolio holdings.
Number of Shares
1,425,000
Previous 866,468
64.46%
Holding current value
$62.9 Million
Previous $36.4 Million
45.03%
% of portfolio
4.73%
Previous 3.14%
Shares
13 transactions
Others Institutions Holding CLDX
# of Institutions
195Shares Held
63.4MCall Options Held
206KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$357 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$165 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$150 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$147 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $2.07B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...